A Study in Healthy Participants Investigating Biomarkers After Exposure to Heparin When Heparin is Administered in the Fasted State or After a High-fat Meal. Heparin, a Registered Drug, is an Anticoagulant (Blood Thinner) That Prevents the Formation of Blood Clots.

EARLY_PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

December 17, 2021

Primary Completion Date

January 11, 2022

Study Completion Date

January 17, 2022

Conditions

Healthy Volunteers

Interventions

DRUG

Heparin

intravenous \[iv\] injection

Trial Locations (1)

Novo Nordisk Investigational Site, Groningen